For Healthcare Professionals

Connect® MM- The Multiple Myeloma Disease Registry

clipboard-pencil

About the study

The purpose of the Connect® MM Registry is to explore the natural history and real world management of patients with newly diagnosed symptomatic multiple myeloma (MM) and provide unique insights into the management of MM and the impact of this hematologic disorder on patients.
user-3

Who can take part

You may be eligible to participate in the study if you meet the following criteria:

INCLUSION CRITERIA

  1. Newly diagnosed with symptomatic MM within 2 months of enrollment in Connect®MM registry
  2. Age ≥18 years
  3. Willing and able to provide signed informed consent
  4. Agrees to complete patient assessment questionnaires either alone or with minimal assistance from caregivers and/or trained site personnel

EXCLUSION CRITERIA

  1. None
pin location

Study Locations

Enter your ZIP code/Postal code/PIN code to locate study sites near you:

How to Apply


Contact the study center to learn if this study is a good match for you.
Phone iconCall 908-219-0789Email iconEmail Study Center

Study’s details


Contition

Multiple Myeloma

Age

18+

Participants needed

3011

Est. Completion Date

Dec 2024

Treatment type

Observational


Sponsor

Celgene

ClinicalTrials.gov identifier

NCT01081028

Study number

Connect MM

Understanding Clinical Trials


Get answers to your questions about clinical trials.What is a clinical research?What does taking part in clinical trials involve?What should I ask the trial doctor?
Vector

Interested?

Sign up to save your favorites, 
receive newsletters, resources, and alerts 
about clinical trials related to your conditions of interest.